← Leaderboards
William Fischer
Univ Of North Carolina Chapel Hill
$5,095,957
Attributed
$9,958,680
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,958,680 · 5
By mechanism
R01$9,023,779 · 3
K23$782,901 · 1
R03$152,000 · 1
Top collaborators
- David A Wohl13 shared
- John Scribner Schieffelin3 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Hinh Ly$4,358,390
- David A Wohl$27,961,733
- Nora Franceschini$10,115,290
- Toni Darville$28,754,279
- Nilu Goonetilleke$10,203,419
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralInfectionVirus DiseasesEpidemicVirusSierra LeonePublic HealthInflammationSurvivorsSymptomsPublic Health RelevanceClinical ResearchLiberiaImmune ActivationEbola VirusCohortAfricaDisease OutbreaksReportingImmuneImmune ResponseCessation Of LifeVirus ReplicationHealthcare
Grant awards (19)
The Protective and Pathologic Features of the EVD Survivor Immune System$697,315
R01 · FY2025 · AI · contact PI
The Protective and Pathologic Features of the EVD Survivor Immune System$691,767
R01 · FY2024 · AI · contact PI
The Protective and Pathologic Features of the EVD Survivor Immune System$715,921
R01 · FY2023 · AI · contact PI
Prevalence, Pathogenesis, and Persistence of Lassa Fever in West Africa$725,157
R01 · FY2022 · AI
Prevalence, Pathogenesis, and Persistence of Lassa Fever in West Africa$727,837
R01 · FY2021 · AI
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease$642,920
R01 · FY2021 · AI
Prevalence, Pathogenesis, and Persistence of Lassa Fever in West Africa$724,693
R01 · FY2020 · AI
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease$647,747
R01 · FY2020 · AI
Prevalence, Pathogenesis, and Persistence of Lassa Fever in West Africa$729,986
R01 · FY2019 · AI
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease$648,834
R01 · FY2019 · AI
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease$199,568
K23 · FY2019 · AI · contact PI
Prevalence, Pathogenesis, and Persistence of Lassa Fever in West Africa$751,045
R01 · FY2018 · AI
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease$655,110
R01 · FY2018 · AI
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease$199,568
K23 · FY2018 · AI · contact PI
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease$665,447
R01 · FY2017 · AI
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease$199,568
K23 · FY2017 · AI · contact PI
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease$184,197
K23 · FY2016 · AI · contact PI
The Effect of Aging on LAIV Replication in Human Nasal Epithelial Cells$76,000
R03 · FY2014 · AG · contact PI
The Effect of Aging on LAIV Replication in Human Nasal Epithelial Cells$76,000
R03 · FY2013 · AG · contact PI